Emerging therapies in transthyretin amyloidosis – a new wave of hope after years of stagnancy?
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging therapies in transthyretin amyloidosis – a new wave of hope after years of stagnancy?
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HEART FAILURE
Volume 22, Issue 1, Pages 39-53
Publisher
Wiley
Online
2020-01-08
DOI
10.1002/ejhf.1695
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee
- (2019) Merrill D. Benson et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis
- (2019) Scott D. Solomon et al. CIRCULATION
- Clinical Experience Using Doxycycline and Ursodeoxycholic Acid for the Treatment of Transthyretin Cardiac Amyloidosis
- (2019) Erin Karlstedt et al. JOURNAL OF CARDIAC FAILURE
- Therapeutic Antisense Oligonucleotides Are Coming of Age
- (2019) C. Frank Bennett Annual Review of Medicine
- POTENTIAL REVERSAL OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY WITH TTR SPECIFIC ANTISENSE OLIGONUCLEOTIDE THERAPY
- (2018) Noel Rakhi Dasgupta et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
- (2018) Merrill D. Benson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis
- (2018) Duncan B. Richards et al. Science Translational Medicine
- Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
- (2018) Mathew S. Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial
- (2017) Peter J. Dyck et al. MUSCLE & NERVE
- Overcoming cellular barriers for RNA therapeutics
- (2017) Steven F Dowdy NATURE BIOTECHNOLOGY
- Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis
- (2016) James S. Butler et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides
- (2016) Elizabeth J. Ackermann et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin
- (2016) Jeffrey N. Higaki et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Novel Antibody for the Treatment of Transthyretin Amyloidosis
- (2016) Akihiko Hosoi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Long-term treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a clinical and neurophysiological study
- (2016) Violaine Planté-Bordeneuve et al. JOURNAL OF NEUROLOGY
- Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area
- (2016) A. Cortese et al. JOURNAL OF NEUROLOGY
- Clinical measures in transthyretin familial amyloid polyneuropathy
- (2016) Teresa Coelho et al. MUSCLE & NERVE
- Alnylam terminates revusiran program, stock plunges
- (2016) Ken Garber NATURE BIOTECHNOLOGY
- Evaluation of Therapeutic Oligonucleotides for Familial Amyloid Polyneuropathy in Patient-Derived Hepatocyte-Like Cells
- (2016) Christoph J. Niemietz et al. PLoS One
- Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses
- (2016) Natalie J. Galant et al. Scientific Reports
- Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy)
- (2015) Younhee Cho et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis
- (2015) Yoshiki Sekijima et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- The effect of tafamidis on the QTcinterval in healthy subjects
- (2015) Karen J. Klamerus et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Tafamidis in Transthyretin Amyloid Cardiomyopathy: Effects on Transthyretin Stabilization and Clinical Outcomes
- (2015) M. S. Maurer et al. Circulation-Heart Failure
- Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study
- (2015) Fabian aus dem Siepen et al. Clinical Research in Cardiology
- Polymer-doxycycline conjugates as fibril disrupters: An approach towards the treatment of a rare amyloidotic disease
- (2015) Inmaculada Conejos-Sánchez et al. JOURNAL OF CONTROLLED RELEASE
- Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments
- (2015) Yoshiki Sekijima JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component
- (2015) Duncan B. Richards et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
- (2015) Ole B Suhr et al. Orphanet Journal of Rare Diseases
- Cardiac Findings and Events Observed in an Open-Label Clinical Trial of Tafamidis in Patients with non-Val30Met and non-Val122Ile Hereditary Transthyretin Amyloidosis
- (2015) Thibaud Damy et al. Journal of Cardiovascular Translational Research
- Repurposing Diflunisal for Familial Amyloid Polyneuropathy
- (2015) John L. Berk et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Physiological IgM Class Catalytic Antibodies Selective for Transthyretin Amyloid
- (2014) Stephanie A. Planque et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trials
- (2014) N. Suanprasert et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area
- (2014) Ryoichi Takahashi et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Norfolk QOL-DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy
- (2014) Etta J. Vinik et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Left Ventricular Amyloid Deposition in Patients With Heart Failure and Preserved Ejection Fraction
- (2014) Selma F. Mohammed et al. JACC-Heart Failure
- Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis
- (2013) Thibaud Damy et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy
- (2013) P. Lozeron et al. EUROPEAN JOURNAL OF NEUROLOGY
- Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
- (2013) Teresa Coelho et al. JOURNAL OF NEUROLOGY
- Argonaute proteins: functional insights and emerging roles
- (2013) Gunter Meister NATURE REVIEWS GENETICS
- Transthyretin Aggregate-Specific Antibodies Recognize Cryptic Epitopes on Patient-Derived Amyloid Fibrils
- (2013) Monichan Phay et al. REJUVENATION RESEARCH
- Effects of Tafamidis on Transthyretin Stabilization and Clinical Outcomes in Patients with Non-Val30Met Transthyretin Amyloidosis
- (2013) Giampaolo Merlini et al. Journal of Cardiovascular Translational Research
- Antibody therapy for familial amyloidotic polyneuropathy
- (2012) Yu Su et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study
- (2012) Laura Obici et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Green tea halts progression of cardiac transthyretin amyloidosis: an observational report
- (2012) Arnt V. Kristen et al. Clinical Research in Cardiology
- The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug
- (2012) Steven M. Johnson et al. JOURNAL OF MOLECULAR BIOLOGY
- Potential Use of Lactosylated Dendrimer (G3)/α-Cyclodextrin Conjugates as Hepatocyte-Specific siRNA Carriers for the Treatment of Familial Amyloidotic Polyneuropathy
- (2012) Yuya Hayashi et al. MOLECULAR PHARMACEUTICS
- Liver transplantation and transthyretin amyloidosis
- (2012) Merrill D. Benson MUSCLE & NERVE
- Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial
- (2012) T. Coelho et al. NEUROLOGY
- Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy
- (2012) T. Yamashita et al. NEUROLOGY
- Epigallocatechin-3-Gallate as a Potential Therapeutic Drug for TTR-Related Amyloidosis: “In Vivo” Evidence from FAP Mice Models
- (2012) Nelson Ferreira et al. PLoS One
- Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade
- (2012) C. E. Bulawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention
- (2011) Janos Szebeni et al. ADVANCED DRUG DELIVERY REVIEWS
- Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation
- (2011) Nelson Ferreira et al. FEBS LETTERS
- Familial amyloid polyneuropathy
- (2011) Violaine Planté-Bordeneuve et al. LANCET NEUROLOGY
- Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis
- (2010) Stephanie Lehrke et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- The Crystal Structure of the Green Tea Polyphenol (−)-Epigallocatechin Gallate−Transthyretin Complex Reveals a Novel Binding Site Distinct from the Thyroxine Binding Site,
- (2010) Masanori Miyata et al. BIOCHEMISTRY
- Synergy of combined Doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models
- (2010) Isabel Cardoso et al. Journal of Translational Medicine
- Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
- (2010) Karl Bodin et al. NATURE
- Transthyretin-related amyloidoses and the heart: a clinical overview
- (2010) Claudio Rapezzi et al. Nature Reviews Cardiology
- Transthyretin: the servant of many masters
- (2009) Joel N. Buxbaum et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Ribonuclease H: the enzymes in eukaryotes
- (2009) Susana M. Cerritelli et al. FEBS Journal
- Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity
- (2009) Nelson Ferreira et al. FEBS LETTERS
- Development of Lipidoid–siRNA Formulations for Systemic Delivery to the Liver
- (2009) Akin Akinc et al. MOLECULAR THERAPY
- Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of Familial Amyloidotic Polyneuropathy
- (2008) Bárbara Macedo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
- (2008) Dagmar E Ehrnhoefer et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation